(Q37895459)

24 August 2017

1 reference

title

Early detection of CKD: the benefits, limitations and effects on prognosis (English)

1 reference

24 August 2017

1

Adeera Levin

1 reference

24 August 2017

Paul E Stevens

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

28 June 2011

1 reference

Nature Reviews Nephrology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

446-457

1 reference

How can we achieve global equity in provision of renal replacement therapy?

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

An economic evaluation of early versus late referral of patients with progressive renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Screening for proteinuria in US adults: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The cost of implementing UK guidelines for the management of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Economic burden of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The UK model for system redesign and chronic kidney disease services

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Reporting of estimated GFR in the primary care clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Two Years After a Quality Improvement Intervention for Chronic Kidney Disease Care in a Primary Care Office

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Cystatin C identifies chronic kidney disease patients at higher risk for complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Combining GFR and albuminuria to classify CKD improves prediction of ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Relation between kidney function, proteinuria, and adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Predicting the Risk of Dialysis and Transplant Among Patients With CKD: A Retrospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Risk factors for end-stage renal disease: 25-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

A predictive model for progression of chronic kidney disease to kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Unreferred chronic kidney disease: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The impact of automated eGFR reporting and education on nephrology service referrals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Referral patterns to renal services: what has changed in the past 4 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Long-term prognosis after acute kidney injury requiring renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Diagnosing chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

A population-based study of the incidence and outcomes of diagnosed chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Progression of kidney dysfunction in the community-dwelling elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Factors associated with kidney disease progression and mortality in a referred CKD population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Progression of nephropathy in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The early impact of the United Kingdom Chronic Kidney Disease (CKD) guidelines on the number of new attendances at renal clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Early recognition and prevention of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Socio-economic status, ethnicity and geographical variations in acceptance rates for renal replacement therapy in England and Wales: an ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Hospital-acquired renal insufficiency: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Risk factors for acute renal failure: inherent and modifiable risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Cardiovascular risk factors and incident acute renal failure in older adults: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The risk of acute renal failure in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Acute kidney injury increases risk of ESRD among elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The nexus of acute kidney injury, chronic kidney disease, and World Kidney Day 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Albuminuria and Estimated Glomerular Filtration Rate Independently Associate with Acute Kidney Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Atherosclerosis in CKD: differences from the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insuffic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Acute myocardial infarction and renal dysfunction: a high-risk combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

"Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Diabetes risk evaluation and microalbuminuria (DREAM) studies: ten years of participatory research with a First Nation's home and community model for type 2 diabetes care in Northern Saskatchewan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of r

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Guidelines for the management of chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Kidney function and use of recommended medications after myocardial infarction in elderly patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Screening for renal disease--what can be learned from the Okinawa experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Correction of anemia with epoetin alfa in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.86

Relationship between nephrologist care and progression of chronic kidney disease.

31 March 2020

1 reference

12 December 2020

Acute Renal Failure in Critically Ill Patients A Multinational, Multicenter Study

1 reference

12 December 2020

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

12 December 2020

Reducing premature death and renal failure in Australian aboriginals. A community-based cardiovascular and renal protective program

1 reference

12 December 2020

The CARI guidelines. Prevention of progression of kidney disease: weight reduction in obese patients with chronic kidney disease

1 reference

12 December 2020

Promoting pre-emptive or early kidney transplantation

1 reference

12 December 2020

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

1 reference

12 December 2020

UK Renal Registry 12th Annual Report (December 2009): chapter 16: international comparisons with the UK RRT programme.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2011.86

1 reference

release_h3smb7hynze4ta5qav7k4qwz2a

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h3smb7hynze4ta5qav7k4qwz2a

24 November 2022

mapped directly with Wikidata item

1 reference